Radiation therapy before surgery cuts pancreatic cancer patients death riskNovember 26th, 2008 - 12:00 pm ICT by ANI
Washington, Nov 26 (ANI): A new study by researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has shown that administering radiation therapy prior to surgery nearly doubles survival in pancreatic cancer patients with operable tumours.
Until now, the authors are aware of no major study that has suggested that neoadjuvant radiation had any distinct advantage over postoperative radiation in terms of survival for patients with resectable tumours.
In this retrospective analysis, study’’s senior author, Dr. David Sherr, assistant professor of clinical radiation oncology at Weill Cornell Medical College, and a radiation oncologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and colleagues analyzed data from 3,885 cases of resected pancreatic cancer, recorded between 1994 and 2003 as part of the national Surveillance, Epidemiology and End Results (SEER) registry database.
Of these cases, 2,337 (60 percent) of patients had received surgery alone, 1,478 (38 percent) received radiation after resection, and 70 (2 percent) received neoadjuvant radiation therapy.
The authors found that the overall survival of patients who received neoadjuvant radiation was 23 months, compared with 17 months for those receiving post-surgical radiotherapy and just 12 months for patients who received surgery alone.
Controlling for variables such as patient age, sex, cancer stage, grade and year of diagnosis, they found that neoadjuvant radiation cut the death risk for patients by 45 percent compared with other treatment strategies, and by 37 percent compared with radiation performed after surgery.
“It may be that in shrinking the tumour, pre-operative radiation gives the surgeon more of a margin of healthy tissue to work with. Because of that, patients are less likely to have microscopic residual disease,” Dr. Sherr said.
He stressed that the findings do need to be verified by a randomised, prospective trial before any firm recommendations can be made. Dr. Sherr is hopeful that such a trial will be conducted in the future.
“In the meantime, this is really heartening news for patients. It suggests that there may be a real advantage to pre-operative radiation. Right now, when a pancreatic tumor is deemed operable, patients typically go straight to surgery. This suggests that in some cases at least we may be able to boost the odds of cure if we employ radiation first. More study is needed, but I believe this type of research has the potential to change practice,” Dr. Sherr said.
The study is published in the Nov. 15 issue of the International Journal of Radiation Oncology, Biology and Physics. (ANI)
- Preoperative chemo response could predict survival in pancreatic cancer patients - May 30, 2010
- New technique to help men become fathers post chemotherapy - Mar 15, 2011
- Bariatric surgery cuts long-term cardiovascular risk in diabetics - Mar 31, 2011
- New method detects aggressive prostate cancer - Aug 09, 2012
- Trial underway to test whether surgery is best option for type 2 diabetes - Feb 11, 2011
- India witnessing rise in pancreatic cancer, say doctors - Oct 06, 2011
- New gene therapy reverses Parkinson's symptoms - Mar 17, 2011
- Aggressive surgery best for kids with brain tumors - Nov 23, 2010
- Gene therapy to brain may treat major depression - Oct 21, 2010
- Sunless tanning spray may help heal post-surgery wounds - Jun 01, 2010
- Novel test to predict breast cancer metastasis - Mar 28, 2009
- Robotic surgery shows promise for head and neck cancer - Dec 21, 2010
- 'Wall Street' star Michael Douglas's cancer is curable: Doctors - Sep 02, 2010
- General anesthesia 'puts brain into a state of reversible coma, not sleep' - Dec 30, 2010
- Why statins work for some people, but not for all - Apr 22, 2010
Tags: cancer patients, cancer stage, clinical radiation oncology, cornell medical center, cornell medical college, death risk, distinct advantage, national surveillance, pancreatic cancer, patient age, presbyterian hospital, radiation oncologist, radiation therapy, registry database, residual disease, retrospective analysis, terms of survival, weill cornell medical, weill cornell medical center, weill cornell medical college